Lv33
270 积分 2022-08-04 加入
Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer
1个月前
已完结
Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma
1个月前
已完结
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual targeting antibody overcome antigen heterogeneity in AML
1个月前
已完结
Development of novel humanized CD19/BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B‐cell lineage neoplasms
1个月前
已完结
Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma
1个月前
已完结
Enhancing the antitumor activity of CD19/BCMA CAR-T cells in vitro with a PD1IL7R chimeric switch receptor
1个月前
已完结
EXPRESS: Targeted therapy of multiple myeloma by IL21-NKG2D CAR-T cells
2个月前
已完结
The i3+3 design for phase I clinical trials
2个月前
已完结
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
3个月前
已完结
Gastric cancer
4个月前
已完结
皖公网安备34019202002308
